Position in IGC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$183,189
New position
Shares Held
678,480
first reported quarter
Ownership
0.656%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#4
of 34 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026AdvisorShares Investments LLC holds $30,504,172 across 21 Biotechnology names. IGC ranks #17 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
121,381 | $5,709,762 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
882,892 | $4,652,840 | |
| 3 | RLMD |
Relmada Therapeutics, Inc.
|
438,901 | $3,037,194 | |
| 4 | NRXP |
NRX Pharmaceuticals, Inc.
|
659,018 | $2,695,383 | |
| 5 | HELP |
Cybin Inc.
|
292,711 | $1,934,819 | |
| 6 | GHRS |
GH Research PLC
|
71,267 | $1,915,656 | |
| 7 | ANRO |
Alto Neuroscience, Inc.
|
70,748 | $1,867,039 | |
| 8 | DRUG |
Bright Minds Biosciences Inc.
|
24,274 | $1,704,034 |
All Filings in IGC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,189 | 678,480 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||